FDA NDC Directory · JSON-LD · Markdown

Darifenacin

NDC 33342-277 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207302
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsDARIFENACIN HYDROBROMIDE (15 mg/1)
Marketing started20170729
Package count3

External sources

Source: openFDA. Public-domain (CC0).